TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway.

Zhang LY, Zhang YQ, Zeng YZ, Zhu JL, Chen H, Wei XL, Liu LJ
Breast Cancer Res Treat. 2020 Jul;182(1):21-33. doi: 10.1007/s10549-020-05673-8. Epub 2020 May 15. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.